Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer

被引：0
|
作者：
François Audenet
Adam M. Farkas
Harry Anastos
Matthew D. Galsky
Nina Bhardwaj
John P. Sfakianos
机构：
[1] Icahn School of Medicine at Mount Sinai,Department of Urology
[2] Icahn School of Medicine at Mount Sinai,Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute
来源：
World Journal of Urology | 2018年 / 36卷
关键词：
BCG; Immune checkpoints; Immune phenotype; Non-muscle invasive bladder cancer; Peripheral blood mononuclear cells; Predictive factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1741 / 1748
页数：7
相关论文
共 50 条
  • [41] Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
    Magalhaes, Joana C.
    Sousa, Maria
    Basto, Raquel
    Fraga, Teresa
    Gomes, Ines
    Fernandes, Catarina
    Mariano, Monica
    Paulo, Judy
    Madeira, Pedro
    Sousa, Gabriela
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
  • [42] BENEFITS AND COSTS OF ALTERNATIVE GUIDELINES FOR SURVEILLANCE OF HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER (NMIBC)
    Su, Zhuo T.
    Mahon, Katherine
    Rezaee, Michael
    Patel, Sunil
    Townsend, Jeffrey
    Kates, Max
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1169 - E1170
  • [43] No 'one size fits all' approach in the management of high-risk non-muscle invasive bladder cancer
    Mostafid, Hugh
    SCANDINAVIAN JOURNAL OF UROLOGY, 2021, 55 (01) : 53 - 53
  • [44] High-risk Non-muscle Invasive Bladder Cancer - "The Real Deal" for Blue Light Cystoscopy and TURBT?
    Geavlete, P.
    Geavlete, B.
    Jecu, M.
    Multescu, R.
    Georgescu, D.
    Dragutescu, M.
    BJU INTERNATIONAL, 2010, 106 (01) : 6 - 6
  • [45] New Intravesical Agents for BCG-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer
    Asimakopoulos, Anastasios D.
    Kochergin, Maxim
    Colalillo, Gaia
    Fahmy, Omar
    Hassan, Fahmy
    Renninger, Markus
    Gallioli, Andrea
    Gavrilov, Pavel
    Gakis, Georgios
    BLADDER CANCER, 2023, 9 (03) : 237 - 251
  • [46] New immunotherapies for high-risk non-muscle invasive bladder cancer: Current state and future perspectives
    Gomez del Canizo, C.
    Rodriguez-Izquierdo Jimenez, M.
    Pena Vallejo, E.
    Duarte Ojeda, J. M.
    de la Rosa Kehrman, F.
    Rodriguez Antolin, A.
    Guerrero Ramos, F.
    ACTAS UROLOGICAS ESPANOLAS, 2020, 44 (09): : 574 - 585
  • [47] The long term outcome of high risk non-muscle invasive bladder cancer
    Thomas, F.
    Rubin, N.
    Goepel, J.
    Abbod, M. F.
    Rosario, D.
    Catto, J. W. F.
    EUROPEAN UROLOGY SUPPLEMENTS, 2012, 11 (01) : E965 - U26
  • [48] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Mayr, Roman
    Burger, Maximilian
    CURRENT UROLOGY REPORTS, 2013, 14 (02) : 90 - 93
  • [49] Value of Fluorescence Cystoscopy in High Risk Non-muscle Invasive Bladder Cancer
    Roman Mayr
    Maximilian Burger
    Current Urology Reports, 2013, 14 : 90 - 93
  • [50] Outcomes of upfront radical cystectomy and orthotopic bladder in patients with high risk non-muscle invasive bladder cancer
    Salam, M. A.
    Haque, M. E.
    Islam, F.
    Kaiser, I.
    Shahinul, I.
    Imrul, T.
    Maula, G.
    Shafiqur, R.
    Hasan, S.
    Hasan, Z.
    Saha, P.
    BJU INTERNATIONAL, 2017, 119 : 10 - 11
12345